Studies care needs of lung cancer patients receiving immunotherapy
Observes quality of life and care needs in adults with lung cancer on immunotherapy.
Key facts
- Who runs it
- National Taiwan University Hospital
- Where
- Taipei, TaiwanSee the site
- Trial code
- Registry title
- Care Needs in Lung Cancer Patients Receiving Immunotherapy
- Status
- Recruiting
- People taking part
- 180 people, planned
- Started
- 21 Apr 2021
- Expected to end
- 31 Dec 2027
- Type of study
- Observational
- Record updated
- 31 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for adults with a malignant lung tumour who have had immunotherapy in the past or are having it now. They fill in a questionnaire.
- Age
- 20 years or older
- Sex
- All sexes can join.
- Disease stage
- Malignant lung tumour, confirmed by imaging or by tissue examination after surgery.
- Earlier treatment
- Must have had immunotherapy in the past or be having it now.
Main reasons for not taking part
- Significant cognitive problems that make it impossible to fill in the questionnaire
- Cannot communicate in Mandarin or Taiwanese
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Individuals diagnosed with malignant lung tumors based on imaging or post-surgical histopathological examination results by specialized physicians
- Individuals who have received immunotherapy in the past or are currently undergoing immunotherapy
- Research participants who are conscious, aged 20 years or older, able to communicate in Mandarin or Taiwanese, capable of completing the questionnaire, willing to participate in the study, and have signed the research consent form
Who cannot take part
- Individuals with significant cognitive impairments who are unable to complete the questionnaire
- Individuals who are unable to communicate in Mandarin or Taiwanese
Where in Taiwan
- National Taiwan University Cancer CenterTaipei, TaiwanContact: Meng Ping Hsiao, MasterTaking people
About the trial
What the trial wants to find out
Lung cancer ranks as the leading cause of cancer-related deaths globally and is among the most common malignancies. In recent years, the advancements in immune checkpoint inhibitors have marked a significant breakthrough in the immunotherapy of lung cancer. However, immunotherapy is a relatively new treatment modality, and ongoing clinical trials continue to explore its efficacy. Due to a lack of knowledge about immunotherapy-related care, patients often experience uncertainty and anxiety regarding its effectiveness, resulting in associated care needs.
Read full original descriptionShow less
A total of 160 lung cancer patients were included in the study. The research findings revealed statistically significant correlations (p < 0.05) between the severity of disease, symptomatology, overall health status, functional capacity, cognitive function, disease progression, mood, and general supportive care needs, as well as specific needs of lung cancer patients.
Regarding factors influencing care needs, it was found that general supportive care needs were significantly influenced by marital status, average personal monthly income, and disease progression. Additionally, age, surgical history, functional capacity, and cognitive function significantly influenced specific care needs. Based on these statistical findings, it is crucial for nursing staff to closely monitor changes in patients' symptoms and mood and provide timely care and support. Furthermore, future interventions should focus on addressing the heightened needs of lung cancer patients, thereby reducing their dissatisfaction along the cancer treatment journey.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Quality of Life, Symptom Severity, and Care Needs in Lung Cancer Patients Receiving Immunotherapy
- Plain-language title
- Studies care needs of lung cancer patients receiving immunotherapyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 31 July 2026